282 related articles for article (PubMed ID: 16123970)
21. Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype.
Bossler AD; Richards J; George C; Godmilow L; Ganguly A
Hum Mutat; 2006 Jul; 27(7):667-75. PubMed ID: 16752392
[TBL] [Abstract][Full Text] [Related]
22. Clinical features and mutations in the ENG, ACVRL1, and SMAD4 genes in Korean patients with hereditary hemorrhagic telangiectasia.
Lee ST; Kim JA; Jang SY; Kim DK; Do YS; Suh GY; Kim JW; Ki CS
J Korean Med Sci; 2009 Feb; 24(1):69-76. PubMed ID: 19270816
[TBL] [Abstract][Full Text] [Related]
23. Hepatic manifestation is associated with ALK1 in hereditary hemorrhagic telangiectasia: identification of five novel ALK1 and one novel ENG mutations.
Kuehl HK; Caselitz M; Hasenkamp S; Wagner S; El-Harith el-HA; Manns MP; Stuhrmann M
Hum Mutat; 2005 Mar; 25(3):320. PubMed ID: 15712270
[TBL] [Abstract][Full Text] [Related]
24. Visceral manifestations in hereditary haemorrhagic telangiectasia type 2.
Abdalla SA; Geisthoff UW; Bonneau D; Plauchu H; McDonald J; Kennedy S; Faughnan ME; Letarte M
J Med Genet; 2003 Jul; 40(7):494-502. PubMed ID: 12843319
[TBL] [Abstract][Full Text] [Related]
25. Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells.
Albiñana V; Bernabeu-Herrero ME; Zarrabeitia R; Bernabéu C; Botella LM
Thromb Haemost; 2010 Mar; 103(3):525-34. PubMed ID: 20135064
[TBL] [Abstract][Full Text] [Related]
26. The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.
Pawlikowska L; Nelson J; Guo DE; McCulloch CE; Lawton MT; Young WL; Kim H; Faughnan ME;
Am J Med Genet A; 2015 Jun; 167(6):1262-7. PubMed ID: 25847705
[TBL] [Abstract][Full Text] [Related]
27. Vascular abnormalities in the fingers of patients affected with hereditary hemorrhagic telangiectasia (HHT) as assessed by color doppler sonography.
Draghi F; Precerutti M; Danesino GM; Olivieri C; Valacca C; Danesino C; Pagella F; Semino L; Lanzarini L; Buscarini E; Danesino C
Am J Med Genet A; 2005 May; 135(1):106-9. PubMed ID: 15779017
[No Abstract] [Full Text] [Related]
28. Hereditary hemorrhagic telangiectasia type 1 and 2 mutations in Finland.
Sankelo M; Halme M; Laitinen T; Mattila PS
Acta Otolaryngol; 2008 Nov; 128(11):1238-41. PubMed ID: 18607909
[TBL] [Abstract][Full Text] [Related]
29. A novel endoglin mutation in hereditary hemorrhagic telangiectasia type 1: a case report.
Lu Y; Zhu Y; Shi L; Zhen H; Sun Z; Cheng L
Mol Med Rep; 2015 Jul; 12(1):510-2. PubMed ID: 25760803
[TBL] [Abstract][Full Text] [Related]
30. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease.
Abdalla SA; Letarte M
J Med Genet; 2006 Feb; 43(2):97-110. PubMed ID: 15879500
[TBL] [Abstract][Full Text] [Related]
31. Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway.
Fernández-L A; Sanz-Rodriguez F; Blanco FJ; Bernabéu C; Botella LM
Clin Med Res; 2006 Mar; 4(1):66-78. PubMed ID: 16595794
[TBL] [Abstract][Full Text] [Related]
32. [Enhancement of the study on the relationship between hereditary hemorrhagic telangiectasia and disorders of blood vessel formation and development].
Zhang GS
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(3):177-8. PubMed ID: 15059528
[No Abstract] [Full Text] [Related]
33. Mutation analysis in Norwegian families with hereditary hemorrhagic telangiectasia: founder mutations in ACVRL1.
Heimdal K; Dalhus B; Rødningen OK; Kroken M; Eiklid K; Dheyauldeen S; Røysland T; Andersen R; Kulseth MA
Clin Genet; 2016 Feb; 89(2):182-6. PubMed ID: 25970827
[TBL] [Abstract][Full Text] [Related]
34. Hereditary hemorrhagic telangiectasia: two distinct ENG deletions in one family.
Wooderchak W; Gedge F; McDonald M; Krautscheid P; Wang X; Malkiewicz J; Bukjiok CJ; Lewis T; Bayrak-Toydemir P
Clin Genet; 2010 Nov; 78(5):484-9. PubMed ID: 20412114
[TBL] [Abstract][Full Text] [Related]
35. What Benjamin Babington, William Osler, Frederick Weber, and Henri Rendu did not know.
Hirschberg R
Cardiovasc Res; 2005 Nov; 68(2):180-2. PubMed ID: 16198324
[No Abstract] [Full Text] [Related]
36. Hereditary hemorrhagic telangiectasia: an update on transforming growth factor beta signaling in vasculogenesis and angiogenesis.
van den Driesche S; Mummery CL; Westermann CJ
Cardiovasc Res; 2003 Apr; 58(1):20-31. PubMed ID: 12667943
[TBL] [Abstract][Full Text] [Related]
37. Life expextancy of parents with Hereditary Haemorrhagic Telangiectasia.
de Gussem EM; Edwards CP; Hosman AE; Westermann CJ; Snijder RJ; Faughnan ME; Mager JJ
Orphanet J Rare Dis; 2016 Apr; 11():46. PubMed ID: 27102204
[TBL] [Abstract][Full Text] [Related]
38. Non-invasive CT screening for pulmonary arteriovenous malformations in children with confirmed hereditary hemorrhagic telangiectasia: Results from two pediatric centers.
Soysal N; Eyries M; Verlhac S; Escabasse V; Remus N; Tamalet A; Rioux JY; Franchi-Abella S; Vasile M; Robert S; Delestrain C; Hau I; Ducou-Le Pointe H; Soubrier F; Carette MF; Epaud R
Pediatr Pulmonol; 2017 May; 52(5):642-649. PubMed ID: 28165669
[TBL] [Abstract][Full Text] [Related]
39. Immunosuppressor FK506 increases endoglin and activin receptor-like kinase 1 expression and modulates transforming growth factor-β1 signaling in endothelial cells.
Albiñana V; Sanz-Rodríguez F; Recio-Poveda L; Bernabéu C; Botella LM
Mol Pharmacol; 2011 May; 79(5):833-43. PubMed ID: 21310938
[TBL] [Abstract][Full Text] [Related]
40. Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers.
Sabbà C; Pasculli G; Lenato GM; Suppressa P; Lastella P; Memeo M; Dicuonzo F; Guant G
J Thromb Haemost; 2007 Jun; 5(6):1149-57. PubMed ID: 17388964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
